Evaluation of efficacy and safety of rituximab in patients with progressive interstitial lung disease (ILD) with inflammatory component (EvER-ILD2): A multicentre double-blind placebo-controlled randomized trial
Titel:
Evaluation of efficacy and safety of rituximab in patients with progressive interstitial lung disease (ILD) with inflammatory component (EvER-ILD2): A multicentre double-blind placebo-controlled randomized trial
Auteur:
Ferreira, Marion Bejan-Angoulvant, Theodora Marchand-Adam, Sylvain Mousset, Elodie Mureau, Elody Jouneau, Stéphane Nunes, Hilario Montani, David Chenivesse, Cécile Cadranel, Jacques Bonniaud, Philippe Crestani, Bruno Cottin, Vincent Caille, Agnès